|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
�ǻ��� |
|
���� |
|
��,��״ϸ�� |
| ��������������� | |
|
������ |
|
���ַ� |
| PubMed | |
|
Article by ������ |
|
Article by ���ַ� |
�չ��Խǻ�������״ϸ����
������1, ���ַ�2
1. ɽ��ʡ����ҽԺƤ���� ̫ԭ 030012;
2. ������ѧ����ҽԺƤ����
�չ��Խǻ�����һ�ֳ�����Ƥ����ǰ����,���ֲ���ɷ�չ����״ϸ����,����״ϸ�����dz����Ժ���������������Ϯ������������Ƥ���������������������Ϻ�������Ϊ��Ҫ�������չ��Խǻ����ķ�����������ܷ�չΪ��״ϸ������ʵ���о���չ��
1. ɽ��ʡ����ҽԺƤ���� ̫ԭ 030012;
2. ������ѧ����ҽԺƤ����
1. ɽ��ʡ����ҽԺƤ���� ̫ԭ 030012;
2. ������ѧ����ҽԺƤ����
[2] Stockfleth E, Meyer T, Benninghoff B, et al. Successful treatment of actinic keratosis with imiquimod cream 5%: a report of six cases. Br J Dermatol, 2001, 144:1050-1053.
[3] Gupta AK, Cooper EA, Feldman SR,et al. A survey of office visits for actinic keratosis as reported by NAMCS, 1990-1999. National Ambulatory Medical Care Survey. Cutis, 2002, 70: 8-13.
[4] Memon AA, Tomenson JA, Bothwell J, et al. Prevalence of solar damage and actinic keratosis in a Merseyside population. Br J Dermatol, 2000, 142:1154-1159.
[5] Persaud AN, Shamuelova E, Sherer D, et al. Clinical effect of imiquimod 5% cream in the treatment of actinic keratosis. J Am Acad Dermatol, 2002, 47:553-556.
[6] Ortonne JP. From actinic keratosis to squamous cell carcinoma. Br J Dermatol, 2002, 146:20-23.
[7] Muramatsu M, Takai S, Miyazaki M. Detections of matrix metalloproteinases activities and localization by film in situ zymography (FIZ).Nippon Yakurigaku Zasshi, 2003, 121:113-118.
[8] Tsukifuji R, Tagawa K, Hatamochi A, et al. Expression of matrix metalloproteinase-1,-2 and-3 in squamous cell carcinoma and actinic keratosis. Br J Cancer, 1999, 80:1087-1091.
[9] Knox PG, Milner AE, Green NK, et al. Inhibition of metalloproteinase cleavage enhances the cytotoxicity of Fas ligand. J Immunol.2003, 170:677-685.
[10] Ramp U, Bretschneider U, Ebert T, et al. Prognostic implications of CD95 receptor expression in clear cell renal carcinomas. Hum Pathol,2003, 34:174-179.
[11] Filipowicz E, Adegboyega P, Sanchez RL, ct al. Expression of CD95 (Fas) in sun-exposed hunan skin and cutaneous carcinomas. Cancer, 2002, 94:814-819.
[12] Bachmann F, Buechner SA, Wernli M, et al. Ultraviolet light downregulates CD95 ligand and TRAIL receptor expression facilitating actinic keratosis and squamous cell carcinoma formation. J Invest Dermatol, 2001, 117:59-66.
[13] Hutchison CJ. Lamins: building blocks or regulators of gene expression? Nat Rev Mol Cell Biol, 2002, 3:848-858.
[14] Oguchi M, Sagara J, Matsumoto K, et al. Expression of lamins depends on epidermal differentiation and transformation. Br J Dermatol,2002, 147:853-858.
[15] Tilli CM, Ramaekers FC, Broers JL, et al. Lamin expression in normal human skin, actinic keratosis, squamous cell carcinoma and basal cell carcinoma. Br J Dermatol, 2003, 148:102-109.
[16] Lee DH, Pfeifer GP. Deamination of 5-methylcytosines within cyclobutane pyrimidine dimers is an important component of UVB mutagenesis. J Biol Chem, 2003, 278:10314-10321.